✦ LIBER ✦

O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa™) in patients with NSCLC: Results of a randomized, double-blind Phase II study

✍ Scribed by Natale, R.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonpré, P.; Dimery, I.; Webster, A.; Ranson, M.

Book ID: 118572651
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 143 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80237-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1124 ORAL Results of a randomized, doubl

1124 ORAL Results of a randomized, double-blind phase II trial of ZD6474 versus gefitinib in patients with NSCLC

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 290 KB

P-497 ZD6474 in combination with carbopl

P-497 ZD6474 in combination with carboplatin and paclitaxel as first-line treatment in patients with NSCLC: Results of the run-in phase of a two-part randomized Phase II study

✍ Hevmach, J.; West, H.; Kerr, R.; Prager, D.; Sandler, A.; Herbst, R.; Stewart, D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Vandetanib Versus Gefitinib in Patients

Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

✍ Natale, R. B.; Bodkin, D.; Govindan, R.; Sleckman, B. G.; Rizvi, N. A.; Capo, A. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 210 KB

A randomized phase II efficacy and safet

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer

✍ Arun A. Azad,Emma K. Beardsley,Sebastian J. Hotte… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 188 KB

Safety of efalizumab in patients with ps

Safety of efalizumab in patients with psoriatic arthritis: results of a phase II, randomized, double-blind, placebo-controlled study

✍ Kim Papp; Phil Mease; Marvin Garovoy; David Zhang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Safety and efficacy of intravenous tigec

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

✍ Carlos Bergallo; Abel Jasovich; Osvaldo Teglia; Maria Eugenia Oliva; Arnold Lent 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 335 KB